Literature DB >> 29288126

High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.

Jonathan R Davies1, Jay Rees1, Sai Man Liu2, K Ravi Acharya3.   

Abstract

Clostridium botulinum neurotoxins (BoNTs) cause the life-threatening condition, botulism. However, while they have the potential to cause serious harm, they are increasingly being utilised for therapeutic applications. BoNTs comprise of seven distinct serotypes termed BoNT/A through BoNT/G, with the most widely characterised being sub-serotype BoNT/A1. Each BoNT consists of three structurally distinct domains, a binding domain (HC), a translocation domain (HN), and a proteolytic domain (LC). The HC domain is responsible for the highly specific targeting of the neurotoxin to neuronal cell membranes. Here, we present two high-resolution structures of the binding domain of subtype BoNT/A3 (HC/A3) and BoNT/A4 (HC/A4) at 1.6 Å and 1.34 Å resolution, respectively. The structures of both proteins share a high degree of similarity to other known BoNT HC domains whilst containing some subtle differences, and are of benefit to research into therapeutic neurotoxins with novel characteristics.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binding domain structure; Botulinum neurotoxin; Clostridium botulinum; Crystallography; Subtypes

Mesh:

Substances:

Year:  2017        PMID: 29288126     DOI: 10.1016/j.jsb.2017.12.010

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  9 in total

1.  Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain.

Authors:  Kyle S Gregory; Tejaswini B Mahadeva; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2022-05-19       Impact factor: 5.075

2.  Rapid Detection of Clostridium botulinum in Food Using Loop-Mediated Isothermal Amplification (LAMP).

Authors:  Yufei Chen; Hao Li; Liu Yang; Lei Wang; Ruyi Sun; Julia E S Shearer; Fengjie Sun
Journal:  Int J Environ Res Public Health       Date:  2021-04-21       Impact factor: 3.390

3.  High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA.

Authors:  Jonathan R Davies; Gavin S Hackett; Sai Man Liu; K Ravi Acharya
Journal:  PeerJ       Date:  2018-03-21       Impact factor: 2.984

Review 4.  Variability of Botulinum Toxins: Challenges and Opportunities for the Future.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2018-09-13       Impact factor: 4.546

Review 5.  Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-12-22       Impact factor: 4.546

6.  Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.

Authors:  Kyle S Gregory; Otsile O Mojanaga; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2022-02-08       Impact factor: 4.546

7.  High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6.

Authors:  Jonathan R Davies; Amy Britton; Sai Man Liu; K Ravi Acharya
Journal:  FEBS Open Bio       Date:  2020-07-23       Impact factor: 2.693

Review 8.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

9.  Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.

Authors:  Kyle S Gregory; Sai Man Liu; K Ravi Acharya
Journal:  FEBS Open Bio       Date:  2020-01-28       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.